The National Institute for Health and Care Excellence (NICE) has recommended obinutuzumab (Gazyvaro, Roche) in combination with mycophenolate mofetil for treating adults with active class 3 or 4 lupus ...
Leukemia and lupus are both conditions that affect the immune system. Although they are different, they share certain symptoms. A person with lupus may have increased risk of developing leukemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results